Notes
Amendments
6 Nov 2020 - Updated report to include 2019 National Drug Strategy Household Survey data.
Australian Institute of Health and Welfare (2020) Alcohol and other drug treatment services in Australia 2018–19, AIHW, Australian Government, accessed 06 November 2024.
Australian Institute of Health and Welfare. (2020). Alcohol and other drug treatment services in Australia 2018–19. Canberra: AIHW.
Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia 2018–19. AIHW, 2020.
Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia 2018–19. Canberra: AIHW; 2020.
Australian Institute of Health and Welfare 2020, Alcohol and other drug treatment services in Australia 2018–19, AIHW, Canberra.
PDF | 2.9MB
In 2018–19, 1,283 publicly funded alcohol and other drug (AOD) treatment services provided just under 220,000 treatment episodes to an estimated 137,000 clients. The four most common drugs that led clients to seek treatment for their own drug use were alcohol (36% of all treatment episodes), amphetamines (28%), cannabis (20%) and heroin (5%). Almost two-thirds (64%) of all clients receiving treatment were male, and the median age of clients was 34 years.
To learn more, see Alcohol and other drug treatment services in Australia 2018–19: key findings.
Note: Content was updated to include 2019 National Drug Strategy Household Survey data on 6 Nov 2020.
COVID-19
This release covers data up to 30 June 2019, preceding COVID-19.
6 Nov 2020 - Updated report to include 2019 National Drug Strategy Household Survey data.